Original paper: A new type of polyphenols-containing dietary supplement for correction of lipids and inflammatory markers in patients with coronary artery disease

[1] Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993;88:2771-27.10.1161/01.CIR.88.6.27718252690Search in Google Scholar

[2] Hollman PC, Geelen A, Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J Nutr 2010;140:600-4;10.3945/jn.109.11663220089788Search in Google Scholar

[3] Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009; 2:270-8.10.4161/oxim.2.5.9498283591520716914Search in Google Scholar

[4] Curin Y, Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep 2005;57(Suppl):97-107.Search in Google Scholar

[5] Tomé-Carneiro J1, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 2013;19:6064-93.10.2174/13816128113199990407378269523448440Search in Google Scholar

[6] Santos AC, Veiga F, Ribeiro AJ. New delivery systems to improve the bioavailability of resveratrol. Expert Opin Drug Deliv 2011;8:973-90.10.1517/17425247.2011.58165521668403Search in Google Scholar

[7] James M, Smoliga JM, Blanchard O. Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules 2014;19:17154-72.10.3390/molecules191117154627095125347459Search in Google Scholar

[8] D’Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia 2015;106:256-71.10.1016/j.fitote.2015.09.01826393898Search in Google Scholar

[9] Lee KH, Park E, Lee HJ, Kim MO, Cha YJ, Kim J, et al. Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr Res Pract 2011;5:28-33.10.4162/nrp.2011.5.1.28306126621487493Search in Google Scholar

[10] Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007;137:2405-11.10.1093/jn/137.11.240517951477Search in Google Scholar

[11] PYCNOGENOL ®. Clinical overview. http://abc.herbalgram.org/site/DocServer/Pycnog_CO.pdf?docID=1762.Search in Google Scholar

[12] Reiner Z Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Nutr Metab Cardiovasc Dis 2013;23:799-807.10.1016/j.numecd.2013.05.00223932901Search in Google Scholar

[13] Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep 2012;14:1-10.10.1007/s11883-011-0219-7369708522102062Search in Google Scholar

[14] Perrone V, Sangiorgi D, Buda S, Degli Esposti L. Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study. Clinicoecon Outcomes Res 2016;8:649-55.10.2147/CEOR.S107992508758827822076Search in Google Scholar

[15] Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, Scorei RI. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris. Effects on lipid profiles inflammation markers and quality of life. Nutrition 2013;29:178-83.10.1016/j.nut.2012.07.00623153742Search in Google Scholar

[16] Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, et al. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2013;27:37-48.10.1007/s10557-012-6427-8355523523224687Search in Google Scholar

[17] Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 2012;32:537-41.10.1016/j.nutres.2012.06.00322901562Search in Google Scholar